Scholarlink

Purpose <p>Cannabidiol (CBD) exhibits potent antioxidant, anti-inflammatory, and neuroprotective properties; however, its therapeutic application in Alzheimer’s disease (AD) is limited by poor aqueous solubility, instability, and restricted brain delivery. This study aimed to develop a nanoparticle-based delivery system to enhance CBD bioavailability and brain-associated therapeutic efficacy.</p> Methods <p>CBD-loaded human serum albumin nanoparticles (CBD-HSA-NPs) were prepared using a modified self-assembly technique. The physicochemical properties, encapsulation efficiency, and in vitro release behavior were characterized. Anti-amyloidogenic activity, reactive oxygen species (ROS) inhibition, and neuroprotective effects were evaluated in vitro. Cellular uptake was assessed in hCMEC/d3 cells using Cy5.5-loaded nanoparticles. In vivo therapeutic efficacy was investigated in an Aβ₁–₄₂-induced AD mouse model through behavioral, biochemical, and histological analyses.</p> Results <p>The optimized CBD-HSA-NPs exhibited a mean particle size of 197.2 ± 1.1&#xa0;nm, a polydispersity index of 0.283, and a zeta potential of − 27.8 ± 0.8 mV, with high encapsulation efficiency (87.4 ± 3.9%) and sustained drug release. Compared with free CBD, CBD-HSA-NPs significantly inhibited Aβ aggregation, reduced ROS generation, and attenuated neuronal toxicity. In hCMEC/d3 cells, Cy5.5-loaded HSA-NPs demonstrated more than two-fold higher cellular uptake than free dye. In Aβ₁–₄₂-injected mice, treatment with CBD-HSA-NPs improved cognitive performance, reduced Aβ burden, and decreased pro-inflammatory cytokines.</p> Conclusion <p>CBD-HSA-NPs represent a promising nanocarrier platform for enhancing CBD delivery and therapeutic efficacy in AD. The formulation demonstrates multifunctional activity, including anti-amyloidogenic, antioxidant, and anti-inflammatory effects, supporting its potential for brain-targeted therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Modified self-assembled cannabidiol–albumin nanoparticles for enhanced brain delivery and neuroprotection in an Alzheimer’s model

  • 期刊论文

  • 发表日期：

    2026年7月23日

查看全文
  • Shrawani Lamichhane,
  • Kanchan Shakhakarmi,
  • Haesoo Kim,
  • Jo-Eun Seo,
  • Sooyeun Lee,
  • Sangkil Lee

摘要

Purpose

Cannabidiol (CBD) exhibits potent antioxidant, anti-inflammatory, and neuroprotective properties; however, its therapeutic application in Alzheimer’s disease (AD) is limited by poor aqueous solubility, instability, and restricted brain delivery. This study aimed to develop a nanoparticle-based delivery system to enhance CBD bioavailability and brain-associated therapeutic efficacy.

Methods

CBD-loaded human serum albumin nanoparticles (CBD-HSA-NPs) were prepared using a modified self-assembly technique. The physicochemical properties, encapsulation efficiency, and in vitro release behavior were characterized. Anti-amyloidogenic activity, reactive oxygen species (ROS) inhibition, and neuroprotective effects were evaluated in vitro. Cellular uptake was assessed in hCMEC/d3 cells using Cy5.5-loaded nanoparticles. In vivo therapeutic efficacy was investigated in an Aβ₁–₄₂-induced AD mouse model through behavioral, biochemical, and histological analyses.

Results

The optimized CBD-HSA-NPs exhibited a mean particle size of 197.2 ± 1.1 nm, a polydispersity index of 0.283, and a zeta potential of − 27.8 ± 0.8 mV, with high encapsulation efficiency (87.4 ± 3.9%) and sustained drug release. Compared with free CBD, CBD-HSA-NPs significantly inhibited Aβ aggregation, reduced ROS generation, and attenuated neuronal toxicity. In hCMEC/d3 cells, Cy5.5-loaded HSA-NPs demonstrated more than two-fold higher cellular uptake than free dye. In Aβ₁–₄₂-injected mice, treatment with CBD-HSA-NPs improved cognitive performance, reduced Aβ burden, and decreased pro-inflammatory cytokines.

Conclusion

CBD-HSA-NPs represent a promising nanocarrier platform for enhancing CBD delivery and therapeutic efficacy in AD. The formulation demonstrates multifunctional activity, including anti-amyloidogenic, antioxidant, and anti-inflammatory effects, supporting its potential for brain-targeted therapy.